Suggestions
Sylvain Sachot
Partner chez Asabys Partners
Sylvain Sachot is an investment professional with extensive experience in the healthcare and biotechnology sectors. Here's a detailed profile of his background and current role:
Professional Background
Sylvain Sachot is currently a Partner at Asabys Partners, a venture capital firm specializing in healthcare investments.13 He joined Asabys at its inception in 2018, bringing with him valuable experience from his previous role at Ysios Capital.1
Education
Sachot's educational background includes:
- Ph.D. in Molecular Medicine from the University of Nantes (2009)1
- Master's degree in Biotechnology (with honors) from University Paris XII1
- MBA from Esade Business School in Barcelona (2014)14
Career Highlights
Academic Experience:: Prior to his venture capital career, Sachot spent a decade in academic research, focusing on gene therapy and regenerative medicine. He completed a postdoctoral fellowship at the Mount Sinai School of Medicine in New York.3
Investment Experience:: At Asabys Partners, Sachot is involved in sourcing, executing, and managing investments in the biopharma and medtech sectors.3
Board Positions
Sylvain Sachot serves on the board of directors for several companies, including:
- Gradient Denervation Technologies
- Anaconda Biomed
- Orikine Bio
He also holds observer positions on the boards of SpliceBio and Medlumics.3
Gradient Denervation Technologies Investment
Sachot played a key role in Asabys Partners' recent investment in Gradient Denervation Technologies. The company secured a €14 million Series A funding round led by Sabadell Asabys, with Sachot commenting on the potential of Gradient's technology to become a first-in-class treatment for patients suffering from heart failure and elevated pulmonary pressures.2
Skills and Expertise
Sachot has a broad understanding of the biopharma and medtech industries, with particular expertise in:
- Gene and cell therapy
- Lysosomal storage disorders
- Investment sourcing and due diligence
He is proficient in French, English, and Spanish.1
Highlights
